Clinical characteristics and predictive models of HER2-low breast cancer patients who only received adjuvant chemotherapy: a real-world retrospective multicenter study

Clinical characteristics and predictive models of HER2-low breast cancer patients who only received adjuvant chemotherapy: a real-world retrospective multicenter study

Abstract HER2-low positivity is reported to play substantial role in neoadjuvant chemotherapy for breast cancer, but its role in adjuvant chemotherapy remains unclear. We aim to explore the role of HER2-low positivity in the breast cancer patients who only received adjuvant chemotherapy. We evaluate...

Full description

Saved in:
Bibliographic Details
Main Authors: Qinchuan Wang, Yuying Wang, Zikang Chen, Yuqing Chao, Lin Chen, Wenjing Li, Xia Yang, Zhinong Jiang, Xiaoyan Li, Bo Gao, Wenxian Hu, Jichun Zhou, Linbo Wang, Haitao Li, Jun Zhang, Qiong Ding, Xudong Lv, Hao Zhang, Heming Zheng
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:npj Precision Oncology
Online Access:https://doi.org/10.1038/s41698-025-00998-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41698-025-00998-3

Similar Items